MARKER THERAPEUTICS, INC. Payments of Financing Costs
MARKER THERAPEUTICS, INC. (MRKR) reported Payments of Financing Costs of $41.50 thousand for the 6-month period ending 2012-06-30, per its 10-Q/A filed 2012-09-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2012-09-12
- MARKER THERAPEUTICS, INC. payments of financing costs for the quarter ending 2011-09-30 was -$3.87K, a 123.98% decline year-over-year.
- MARKER THERAPEUTICS, INC. payments of financing costs for the quarter ending 2010-09-30 was $16.13K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 143 month | Payments of Financing Costs 146 month |
|---|---|---|---|---|---|
| 2012-06-30 | $41.50K 10-Q/A · filed 2012-09-12 | ||||
| 2011-09-30 | -$3.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | -$54.97K 10-Q · filed 2011-11-21 | $10.91K 10-Q · filed 2011-11-21 | ||
| 2011-06-30 | -$51.10K 10-Q · filed 2011-08-22 | $14.78K 10-Q · filed 2011-08-22 | |||
| 2010-09-30 | $16.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | -$41.38K 10-Q · filed 2011-11-21 | |||
| 2010-06-30 | -$57.51K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |